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NF1: Neurofibromatosis type 1INTRODUCTION
Neurofibromatosis type 1 (NF1) is one of the most
common autosomal dominant genetic disorders,
affecting approximately 1 in 3000 live births.1
Although numerous studies suggest an increased
incidence of pregnancy complications in patients
with NF1,2 relatively fewer reports describe the effect
of pregnancy on cutaneous manifestations of NF1.3
Here we report on a patient who had multiple
neurofibromas beginning in the third month of her
first pregnancy leading to a diagnosis of NF1.
CASE REPORT
A 36-year-old gravida 1, para 0woman at 28weeks’
gestationwas referred to the dermatology clinic byher
obstetrician for evaluation of dozens of new papules
and nodules, which had progressively increased in
size andnumber since she first noticed them in the first
trimester of her pregnancy. The patient denied any
other complications during her pregnancy and had
regular follow-upwithherobstetrician throughouther
pregnancy. The patient denied constitutional symp-
toms, and review of systems was only notable for
pruritus of some of the nodules. All results of
laboratory tests done during her pregnancy were
within normal limits. The patient denied a family
history of NF1, and social history was unremarkable.
Onphysical examination, thepatient hadnumerous 3-
to 10-mm dark brown hyperpigmented papules and
soft nodules located primarily on the back, chest,
abdomen, and arms, which were clinically consistent
with neurofibromas (Fig 1). She also had numerous 1-
to 2-mm hyperpigmented freckles on the trunk, face,
and axillae (Fig 2) that she stated were present since
childhood, andmore than6 cafe-au-laitmacules larger
than 1.5 cmon the trunk. In addition, shewas found to
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obayan@bu.edu.right thigh that was clinically consistent with a
plexiform neurofibroma (Fig 3). The patient also had
mild scoliosis. The diagnosis of NF1 was made based
on the major criteria of axillary freckling, cafe-au-lait
macules, and neurofibromas.4 She was referred for
genetic counseling.
DISCUSSION
Several studies have found that in approximately
50% of female NF1 patients, pregnancy leads to
growth in size and number of baseline neuro-
fibromas, but eruptive neurofibromas as the first
presenting sign of neurofibromatosis in pregnancy is
less common (3.1%ofNF1 patients).3 It is unclearwhy
pregnancy often predisposes to increased growth of
neurofibromas. In vitro studies suggest that growth of
neurofibromas may be mediated by estrogen, pro-
gesterone, and androgens as well as epidermal
growth factor, fibroblast growth factor, and trans-
forming growth factor alfa.5,6 Therefore, it is postu-
lated that the physiologic increase in estrogen and
progesterone during pregnancy may explain the
increased growth of neurofibromas during this
period.5 Approximately 22% of patients who experi-
enced proliferation of neurofibromas during preg-
nancy had partial regression of neurofibromas
postpartum,3 although there are no reported cases
of complete resolution. Findings from prior cohort
studies suggest an increased risk of pregnancy
complications in NF1 patients, including preeclamp-
sia, preterm labor, intrauterine growth restric-
tion, hypertension, oligohydramnios, spontaneousJAAD Case Reports 2015;1:23-4.
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Fig 3. Plexiform neurofibroma.
Fig 2. Axillary freckling.
Fig 1. Neurofibromas.
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24 Xiong, Gilchrest, and Obayanabortion, stillbirth, and cesarean section, but more
recent studies have not found the above associations.3
Although our patient has not yet experienced any
pregnancy-related complications, it is important to
remain vigilant throughout her pregnancy and to
provide careful follow-up for her child. Even before
the development of neurofibromas, the patient
manifested diagnostic findings of NF1 (axillaryfreckling and [6 cafe-au-lait spots). Had her
diagnosis of this autosomal dominant disease
preceded her pregnancy, genetic counseling might
have been more timely.
Our case adds to the literature on eruptive
neurofibromas in pregnancy and emphasizes the
desirability of early diagnosis for NF1. With early
diagnosis, appropriate prenatal counseling can be
performed and prompt surveillance for ocular
involvement, vasculopathy, skeletal abnormalities,
malignancies, and learning disabilities can lend to
early treatment of these potential complications. It
is unclear whether there is increased risk of
pregnancy complications in patients with NF1.
Nonetheless, a high clinical index of suspicion is
warranted to monitor for signs of complications
during pregnancy.
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